George Tomy
Internal Medicine · New Hartford, NYNPI 1265426480
Payments from drug & device makers
Across 404 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$799
- Astellas Pharma US Inc$757
- Novo Nordisk$641
- AstraZeneca$582
- Pfizer$430
- GSK$421
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,790100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $799 |
| Astellas Pharma US Inc | 40 | $757 |
| Novo Nordisk | 47 | $641 |
| AstraZeneca | 31 | $582 |
| Pfizer | 34 | $430 |
| GSK | 27 | $421 |
| Lilly USA, LLC | 24 | $346 |
| Boehringer Ingelheim | 20 | $338 |
| Amgen | 17 | $305 |
| Bayer | 14 | $273 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $207 |
| Amarin Pharma, Inc. | 13 | $205 |
| Merck | 13 | $202 |
| Johnson & Johnson | 10 | $167 |
| Novartis | 9 | $155 |
| UCB, Inc. | 4 | $116 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $104 |
| SK Life Science, Inc. | 3 | $99 |
| Sanofi-aventis U.S. LLC | 5 | $89 |
| Shield Therapeutics Inc | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Abbott | 3 | $63 |
| Sunovion Pharmaceuticals Inc. | 4 | $45 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $37 |
| Neurelis, Inc. | 1 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Almatica Pharma LLC | 1 | $32 |
| Dynavax Technologies Corporation | 1 | $30 |
| Exact Sciences | 2 | $28 |
| Eisai Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $14 |
| Smith+Nephew | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$6,796 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 59 | $43,993 |
| LinzessLinaclotide | 65 | $39,430 |
| ProliaDenosumab | 20 | $37,708 |
| JanuviaSitagliptin Phosphate | 52 | $33,372 |
| JardianceEmpagliflozin | 44 | $29,529 |
| XareltoRivaroxaban | 20 | $25,599 |
| AptiomEslicarbazepine Acetate | 15 | $22,857 |
| Baclofen | 155 | $14,367 |
| OzempicSemaglutide | 13 | $14,132 |
| Omeprazole | 519 | $13,498 |
| Levetiracetam | 115 | $10,520 |
| Divalproex Sodium | 45 | $9,972 |
| Rosuvastatin Calcium | 214 | $8,831 |
| DapagliflozinDapagliflozin Propanediol | 12 | $7,140 |
| Sucralfate | 35 | $6,969 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $430 | $43,99359 claims |
| AbbVieLinzess | $799 | $39,43065 claims |
| AmgenProlia | $305 | $37,70820 claims |
| MerckJanuvia | $202 | $33,37252 claims |
| Boehringer IngelheimJardiance | $338 | $29,52944 claims |
| Johnson & JohnsonXarelto | $167 | $25,59920 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $45 | $22,85715 claims |
| Novo NordiskOzempic | $641 | $14,13213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in New Hartford
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.